Pharma Focus Asia

GBT acquires Laboratorio DOSA

Monday, November 13, 2017

GBT-Grupo Biotoscana, a leading biopharmaceutical company in Latin America, today announced the acquisition of Laboratorio DOSA, a specialty pharmaceutical manufacturer based in Argentina. The transaction continues to advance GBT's strategic agenda and expands GBT's scope into the promising area of severe lung diseases. The bulk of DOSA's products treat severe pulmonary pathologies. DOSA posted revenues of ARS326M (BRL61M) in 2016.

The operation was closed at a price of USD29.9M. (approx. BRL 100M).

"Today's announcement is an important milestone for us, as GBT continues to advance its strategic agenda and consolidates its position as the first pan-Latin American advanced medicines company," said Mariano García­Valiño, Chief Executive Officer of the group. "The acquisition will enhance GBT's product portfolio, add further in-house R&D and manufacturing capabilities, strengthen our product renewal pipeline and provide us with a new platform for growth and geographic expansion."

"The combination with GBT will help DOSA reach a number of key countries where the companies' products have significant potential" said Carlos Estevez, Chief Executive Officer of DOSA. "We will also have the opportunity to introduce GBT and DOSA products to each other's markets and customers."

Severe pulmonary diseases are one of the fastest-growing segment of the global pharmaceutical sector, according to a recent study by Allied Market Research.  GBT will seek to capitalize on this significant opportunity by further expanding its regional footprint and diversifying its product portfolio through in-licensing and proprietary R&D.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024